United Kingdom

People: Align Technology Inc (ALGN.OQ)

ALGN.OQ on NASDAQ Stock Exchange Global Select Market

17 Jul 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Siegel, Susan 

Ms. Susan E. Siegel serves as Independent Director of the Company. In November 2017, she was appointed Chief Innovation Officer at GE and Chief Executive Officer of GE Business Innovations, GE's growth and innovation business. Since 2012, she has been Chief Executive Officer of GE Ventures, now subsumed into her new role. Prior to joining GE, from May 2006 to May 2012, she was a General Partner at Mohr Davidow Ventures, where she led healthcare and lifescience investments. From April 1998 to April 2006, Ms. Siegel was at Affymetrix, Inc. where she served as President and as a member of the board of directors. Since February 2019, Ms. Siegel has served on the board of directors of Illumina, Inc., a leading developer, manufacturer and marketer of life science tools and integrated systems for the analysis of genetic variation and function. Ms. Siegel holds a B.S. in Biology from the University of Puerto Rico and a M.S. in Biochemistry and Molecular Biology from Boston University Medical School.

Basic Compensation

Total Annual Compensation, USD 59,167
Restricted Stock Award, USD 300,054
Long-Term Incentive Plans, USD --
All Other, USD --
Fiscal Year Total, USD 359,221

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Charles Larkin


Joseph Hogan


John Morici


Zelko Relic


Raj Pudipeddi


Simon Beard

As Of  31 Dec 2018